Adverse Event Profile of Blinatumomab in Acute Lymphoblastic Leukemia
3 vistas
• 08/04/23
0
0
Empotrar
administrator
Suscriptores
In this segment, Raoul Tibes, MD, PhD, highlights common toxicities to be aware of in patients with acute lymphoblastic leukemia receiving blinatumomab therapy.
Mostrar más
Comentarios de Facebook
SORT BY-
Top Comentarios
-
Últimos comentarios